A recent study on the von Hippel-Lindau tumor suppressor (VHL, also known as E3 ubiquitin protein ligase) suggested that VHL inactivation decreases H3K4Me3 levels through JARID1C, which suppresses tumor growth as well as COL6A1 expression [15]. The gene discussed is COL6A1; the disease is neoplasm.